These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 3365068)

  • 1. Hemodynamic effects of a dihydropyridine calcium antagonist, NB-818 (NPK-1886) in anesthetized dogs.
    Nishikibe M; Nagura J; Kamei K; Fukuroda T
    Arch Int Pharmacodyn Ther; 1988; 291():7-20. PubMed ID: 3365068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the newly synthetized calcium antagonist isopropyl methyl 2-carbamoyloxymethyl-6-methyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5- dicarboxylate on cerebral venous outflow in dogs.
    Nishikibe M; Kamei K; Nagura J; Suzuki K
    Arzneimittelforschung; 1989 Jun; 39(6):678-81. PubMed ID: 2775334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of the calcium antagonist isradipine and some other dihydropyridine derivatives on regional blood flow in anesthetized open-chest dogs.
    Sakanashi M; Noguchi K; Miyamoto Y; Kato T; Nagamine F; Yu WY; Higuchi M; Nakasone J
    Arch Int Pharmacodyn Ther; 1988; 294():159-74. PubMed ID: 2976588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of OPC-13340, a potent, long-acting 1,4-dihydropyridine calcium channel blocker, in dogs.
    Mori T; Nakayama N; Ohura M; Ikezono K; Kinoshita S; Kamata M; Hosokawa T; Yamashita S; Yabuuchi Y
    Arch Int Pharmacodyn Ther; 1993; 321():41-56. PubMed ID: 8323415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the new calcium antagonist 2-nitratopropyl-3-nitratopropyl-2,6-dimethyl-4-(3-nitrophe nyl)- 1,4-dihydropyridine-3,5-dicarboxylate on cerebral circulation in dogs.
    Tsuchida K; Yamazaki R; Kaneko K; Aihara H
    Arzneimittelforschung; 1987 Nov; 37(11):1239-43. PubMed ID: 3481545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilating effects of the new calcium antagonist benidipine hydrochloride in anesthetized dogs and cats.
    Karasawa A; Kubo K; Shuto K; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1707-12. PubMed ID: 3219145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the calcium antagonist NB-818 on cerebral blood flow.
    Nishikibe M; Nakajima A
    Life Sci; 1988; 43(21):1715-23. PubMed ID: 3193855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effects of the new generation calcium antagonist 3-pyridine carboxylic acid 5-[(cyclopropylamino)carbonyl]-1,4-dihydro-2,6-dimethyl-4-(2-nitropheny l) octyl ester.
    Hojo M; Teramoto N; Hata H; Katayama O; Tatsumi H; Shibata S
    Arzneimittelforschung; 1992 May; 42(5):621-8. PubMed ID: 1530674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of a new dihydropyridine calcium antagonist.
    Kimura Y; Fukui H; Tanaka M; Okamoto M; Miura A; Kimura K; Enomoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1336-44. PubMed ID: 3790183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of the new calcium antagonist isradipine and of diltiazem in anesthetized open-chest dogs.
    Sakanashi M; Miyamoto Y; Noguchi K; Kato T; Matsuzaki T; Miyagi H; Ikema S; Kinjo N
    Arzneimittelforschung; 1988 Dec; 38(12):1792-6. PubMed ID: 2977545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M; Fukuroda T; Nakajima A
    Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study on acute antihypertensive effects and pharmacokinetics of nisoldipine, nifedipine, nimodipine and nicardipine administered orally to conscious renal hypertensive dogs.
    Takata Y; Kato H
    Arzneimittelforschung; 1986 Oct; 36(10):1464-71. PubMed ID: 3814208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cardiovascular effects of three dihydropyridine compounds.
    Nagura J; Suzuki K; Shiratori K; Fukuroda T; Nishikibe M; Murayama B; Takeya K
    Arch Int Pharmacodyn Ther; 1989; 302():174-85. PubMed ID: 2636815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional vasodilating and cardiac effects of nicardipine in anaesthetized open chest dog.
    Bongrani S; Razzetti R; Schiantarelli P
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):226-36. PubMed ID: 4004418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiohemodynamic effect of a novel calcium antagonist, SD-3211, in the dog.
    Takada T; Miyawaki N; Nishimura K; Nakata K; Matsuno K; Ishida N; Yamauchi H; Iso T
    Arch Int Pharmacodyn Ther; 1991; 309():75-87. PubMed ID: 1888232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fantofarone (SR 33557): cardiovascular actions in anesthetized dogs.
    Barthélémy G; Chatelain P; Manning A
    Arch Int Pharmacodyn Ther; 1994; 327(2):204-19. PubMed ID: 7979829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.